www.fdanews.com/articles/173268-bolton-receives-ce-mark-approval-for-abdominal-stent-graft-system
![](https://www.fdanews.com/ext/resources/test/Device_Images5/BoltonMedical_logo.png?t=1443738005&width=430)
Bolton Receives CE Mark Approval for Abdominal Stent-Graft System
September 25, 2015
Bolton Medical has received CE Mark for its Treo Abdominal Stent-Graft System used to treat abdominal aortic aneurysms.
According to the Sunrise, Fla.-based company, the three-piece system offers a wide range of sizes that allows for precise treatment and greater patient applicability.
Treo is the latest addition to the Bolton’s abdominal product portfolio.
Bolton is a subsidiary of the WerfenLife Co., which manufactures and distributes medical diagnostic solutions and medical devices around the globe. — Michael Cipriano